Articles

Docetaxel and Cisplatin Plus Chemoradiation in Inoperable Stage III NSCLC

ASCO 2014 – Lung Cancer

Results from RADIANT: Adjuvant Erlotinib in NSCLC

ASCO 2014 – Lung Cancer

Breaking News from the REVEL Study in NSCLC

ASCO 2014 – Lung Cancer

NSCLC Daily News from ASCO 2014: May 30, 2014 – Preview of Key Topics

ASCO 2014 – Lung Cancer

Next-Generation TKIs

ASCO 2014 – Lung Cancer

Value-Based Use of Molecular and Genomic Markers

ASCO 2014 – Lung Cancer

New Results with Existing Agents

ASCO 2014 – Lung Cancer

New Molecular Targets for NSCLC

ASCO 2014 – Lung Cancer

Immune Checkpoint Therapy in NSCLC

ASCO 2014 – Lung Cancer

Prophylactic Cranial Irradiation in the Adjuvant Setting in NSCLC

ASCO 2014 – Lung Cancer

Page 139 of 143